|
KLHL23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.188400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.642300E-02 |
| Normal-vs-Stage2 |
1.106970E-01 |
| Normal-vs-Stage3 |
2.12330000026739E-07 |
| Normal-vs-Stage4 |
1.98250000005284E-06 |
| Stage1-vs-Stage2 |
8.846600E-01 |
| Stage1-vs-Stage3 |
8.969500E-04 |
| Stage1-vs-Stage4 |
1.264260E-03 |
| Stage2-vs-Stage3 |
1.745920E-02 |
| Stage2-vs-Stage4 |
1.113930E-02 |
| Stage3-vs-Stage4 |
5.942000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.35369999999469E-05 |
| Normal-vs-AfricanAmerican |
1.433040E-01 |
| Normal-vs-Asian |
4.053600E-01 |
| Caucasian-vs-AfricanAmerican |
1.324990E-01 |
| Caucasian-vs-Asian |
1.423980E-01 |
| AfricanAmerican-vs-Asian |
7.478200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.381300E-04 |
| Normal-vs-Female |
2.064900E-03 |
| Male-vs-Female |
3.068600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.975800E-02 |
| Normal-vs-Age(41-60Yrs) |
7.806800E-04 |
| Normal-vs-Age(61-80Yrs) |
2.47310000000001E-05 |
| Normal-vs-Age(81-100Yrs) |
4.768000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.293570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.847800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.963200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.343600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.038800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.783600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.236600E-04 |
| Classical-VS-Follicular |
1.881480E-03 |
| Classical-VS-Other |
5.604400E-01 |
| Classical-VS-Normal |
4.162700E-04 |
| Tall-VS-Follicular |
1.0992999999182E-07 |
| Tall-VS-Other |
3.833000E-01 |
| Tall-VS-Normal |
6.51840004195492E-09 |
| Follicular-VS-Other |
1.454810E-01 |
| Follicular-VS-Normal |
9.645800E-01 |
| Other-VS-Normal |
2.859900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.755590E-02 |
| Normal-vs-N1 |
2.634900E-04 |
| N0-vs-N1 |
4.251500E-02 |
|
|
